Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device
US-2023183277-A1 · Jun 15, 2023 · US
US12588404B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12588404-B2 |
| Application number | US-202217841088-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 15, 2022 |
| Priority date | Jul 22, 2021 |
| Publication date | Mar 24, 2026 |
| Grant date | Mar 24, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An organometallic compound, represented by Formula 1: M1(Ln1)n1(Ln2)n2 Formula 1 wherein, in Formula 1, M1 is a transition metal, Ln1 is a ligand represented by Formula 1A, Ln2 is a ligand represented by Formula 1B, n1 is 1 or 2, and n2 is 1 or 2: wherein the substituents of Formulae 1A and 1B are as provided herein in the detailed description.
Opening claim text (preview).
What is claimed is: 1 . An organometallic compound, represented by Formula 1: M 1 (Ln 1 ) n1 (Ln 2 ) n2 Formula 1 wherein, in Formula 1, M 1 is a transition metal, Ln 1 is a ligand represented by Formula 1A, Ln 2 is a ligand represented by Formula 1B, n1 is 1 or 2, n2 is 1 or 2, wherein, in Formulae 1A, 1B, 3B, and 40, CY 1 and CY 2 are each a C 5 -C 30 carbocyclic group or a C 1 -C 30 heterocyclic group, CY 3 is represented by Formula 3B, CY 4 is a group represented by Formula 40, X 1 is C or N, and X 2 is C or N, X 3 is N, and X 4 is C or N, Y 1 is —O—, —S—, —Se—, —C(R 3 )(R 4 )—, —N(R 3 )—, or —B(R 3 )—, Y 41 and Y 42 are each independently a single bond, —O—, —S—, —Se—, —C(R 5 )(R 6 )—, —N(R 5 )—, or —B(R 5 )—, Y 41 and Y 42 are not both a single bond at the same time, X 31 is C(R 31 ) or N, X 32 is C(R 32 ) or N, X 33 is C(R 33 ) or N, X 34 is C(R 34 ) or N, and X 35 is C(R 35 )R 36 ) or N(R 35 ), R 10 and R 20 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, —SF 5 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 1 -C 60 alkylthio group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 7 -C 60 alkyl aryl group, a substituted or unsubstituted C 7 -C 60 aryl alkyl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted C 2 -C 60 alkyl heteroaryl group, a substituted or unsubstituted C 2 -C 60 heteroaryl alkyl group, a substituted or unsubstituted C 1 -C 60 heteroaryloxy group, a substituted or unsubstituted C 1 -C 60 heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, R 1 to R 6 , R 30 , R 31 to R 36 , and R 40 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, —SF 5 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 1 -C 60 alkylthio group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 7 -C 60 alkyl aryl group, a substituted or unsubstituted C 7 -C 60 aryl alkyl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted C 2 -C 60 alkyl heteroaryl group, a substituted or unsubstituted C 2 -C 60 heteroaryl alkyl group, a substituted or unsubstituted C 1 -C 60 heteroaryloxy group, a substituted or unsubstituted C 1 -C 60 heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 1 )(Q 2 )(Q 3 ), —Ge(Q 1 )(Q 2 )(Q 3 ), —N(Q 4 )(Q 5 ), —B(Q 6 )(Q 7 ), —P(Q 8 )(Q 9 ), or —P(═O)(Q 8 )(Q 9 ), when Y 1 is —O—, then at least one R 30 is a group represented by Formulae 10-13 to 10-47, 10-49 to 10-154, 10-204, or 10-205: two or more of a plurality of R 10 (s) are optionally linked together to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group, two or more of a plurality of R 20 (s) are optionally linked together to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group, two or more of a plurality of R 30 (s) are optionally linked together to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group, two or more of a plurality of R 40 (s) are optionally linked together to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group, neighboring two or more of R 1 to R 6 , R 10 , R 20 , R 30 , and R 40 are optionally linked together to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group, b10, b20, and b40 are each independently 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10, in Formulae 1A, and 1B, * and *′ each indicate a binding site to M 1 , in Formula 3B, * indicates a binding site to M 1 and,
of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title
with oxygen · CPC title
containing one nitrogen atom as the heteroatom · CPC title
containing organic luminescent materials · CPC title
Iridium compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.